National Bank of Canada
DNA icon

National Bank of Canada’s Ginkgo Bioworks DNA Stock Holding History

National Bank of Canada’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.69K Buy
+276
New +$2.3K ﹤0.01% 2630
2025
Q3 		– Sell
-493,900
Closed -$5.56M – 2936
2025
Q2 		$5.56M Buy
+493,900
New +$3.83M 0.01% 929
2025
Q1 		– Sell
-305
Closed -$3K – 2921
2024
Q4 		$3K Sell
305
-780
-72% -$6.68K ﹤0.01% 2526
2024
Q3 		$8.84K Buy
1,085
+126
+13% +$1.26K ﹤0.01% 2110
2024
Q2 		$12.4K Hold
959
– – ﹤0.01% 2084
2024
Q1 		$29.2K Buy
959
+192
+25% +$9.94K ﹤0.01% 1923
2023
Q4 		$50.9K Buy
767
+450
+142% +$27.6K ﹤0.01% 1761
2023
Q3 		$21.7K Sell
317
-125
-28% -$9.99K ﹤0.01% 2021
2023
Q2 		$32.7K Buy
442
+19
+4% +$1.13K ﹤0.01% 1896
2023
Q1 		$22.4K Sell
423
-2,393
-85% -$152K ﹤0.01% 1934
2022
Q4 		$190K Buy
2,816
+161
+6% +$14.8K ﹤0.01% 1480
2022
Q3 		$331K Buy
2,655
+1,889
+247% +$225K ﹤0.01% 1245
2022
Q2 		$73K Sell
766
-3,097
-80% -$378K ﹤0.01% 1647
2022
Q1 		$623K Buy
3,863
+3,850
+29,615% +$749K ﹤0.01% 1257
2021
Q4 		$4K Buy
+13
New +$6.17K ﹤0.01% 2570

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

National Bank of Canada's DNA Position: Q1 2026 in Review

National Bank of Canada opened a new position in Ginkgo Bioworks (DNA) in Q1 2026: 276 shares worth $1.69K. The stake represents ﹤0.01% of the portfolio and ranks #2630 among its holdings. This is a return to the name: National Bank of Canada previously reported a position in DNA as recently as Q2 2025.

National Bank of Canada first reported a position in DNA in Q4 2021 and has held it in 15 quarters since. The position peaked at $5.56M in Q2 2025. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • National Bank of Canada held 276 shares of Ginkgo Bioworks worth $1.69K as of Q1 2026.
  • Ginkgo Bioworks was a new National Bank of Canada position in Q1 2026.
  • Ginkgo Bioworks made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2630 holding.
  • National Bank of Canada first reported a position in Ginkgo Bioworks in Q4 2021 and has held it in 15 quarters since.
  • National Bank of Canada's Ginkgo Bioworks position peaked at $5.56M in Q2 2025.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.